Logo image of SHC

SOTERA HEALTH CO (SHC) Stock Price, Forecast & Analysis

USA - NASDAQ:SHC - US83601L1026 - Common Stock

15.65 USD
-0.13 (-0.82%)
Last: 11/20/2025, 12:14:00 PM

SHC Key Statistics, Chart & Performance

Key Statistics
Market Cap4.45B
Revenue(TTM)1.15B
Net Income(TTM)55.42M
Shares284.05M
Float174.03M
52 Week High17.78
52 Week Low9.53
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.81
PE19.32
Fwd PE17.5
Earnings (Next)02-25 2026-02-25/amc
IPO2020-11-20
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


SHC short term performance overview.The bars show the price performance of SHC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20

SHC long term performance overview.The bars show the price performance of SHC in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of SHC is 15.65 USD. In the past month the price decreased by -5.79%. In the past year, price increased by 23.09%.

SOTERA HEALTH CO / SHC Daily stock chart

SHC Latest News, Press Relases and Analysis

SHC Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.52 215.86B
DHR DANAHER CORP 28.89 159.49B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 176.48 53.55B
A AGILENT TECHNOLOGIES INC 26.61 41.11B
IQV IQVIA HOLDINGS INC 18.7 36.97B
MTD METTLER-TOLEDO INTERNATIONAL 33.39 28.78B
WAT WATERS CORP 29.69 22.45B
WST WEST PHARMACEUTICAL SERVICES 36.41 18.51B
ILMN ILLUMINA INC 27.38 18.35B
MEDP MEDPACE HOLDINGS INC 41.38 16.62B
TEM TEMPUS AI INC N/A 11.53B
RVTY REVVITY INC 19.39 10.78B

About SHC

Company Profile

SHC logo image Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Company Info

SOTERA HEALTH CO

9100 South Hills Blvd, Suite 300, Suite 300

Broadview Heights OHIO 44147 US

CEO: Michael B. Petras

Employees: 3000

SHC Company Website

SHC Investor Relations

Phone: 14402621410

SOTERA HEALTH CO / SHC FAQ

What does SHC do?

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.


What is the current price of SHC stock?

The current stock price of SHC is 15.65 USD. The price decreased by -0.82% in the last trading session.


Does SOTERA HEALTH CO pay dividends?

SHC does not pay a dividend.


What is the ChartMill technical and fundamental rating of SHC stock?

SHC has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What sector and industry does SOTERA HEALTH CO belong to?

SOTERA HEALTH CO (SHC) operates in the Health Care sector and the Life Sciences Tools & Services industry.


What is the market capitalization of SHC stock?

SOTERA HEALTH CO (SHC) has a market capitalization of 4.45B USD. This makes SHC a Mid Cap stock.


What is the outstanding short interest for SOTERA HEALTH CO?

The outstanding short interest for SOTERA HEALTH CO (SHC) is 4.11% of its float.


SHC Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to SHC. When comparing the yearly performance of all stocks, SHC is one of the better performing stocks in the market, outperforming 77.51% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

SHC Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to SHC. SHC scores excellent on profitability, but there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SHC Financial Highlights

Over the last trailing twelve months SHC reported a non-GAAP Earnings per Share(EPS) of 0.81. The EPS increased by 8% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.82%
ROA 1.74%
ROE 10.07%
Debt/Equity 4.04
Chartmill High Growth Momentum
EPS Q2Q%52.94%
Sales Q2Q%9.05%
EPS 1Y (TTM)8%
Revenue 1Y (TTM)-15.95%

SHC Forecast & Estimates

12 analysts have analysed SHC and the average price target is 17.8 USD. This implies a price increase of 13.73% is expected in the next year compared to the current price of 15.65.

For the next year, analysts expect an EPS growth of 13.43% and a revenue growth 5.13% for SHC


Analysts
Analysts81.67
Price Target17.8 (13.74%)
EPS Next Y13.43%
Revenue Next Year5.13%

SHC Ownership

Ownership
Inst Owners54.34%
Ins Owners2.46%
Short Float %4.11%
Short Ratio3.44